90 related articles for article (PubMed ID: 3162072)
1. Changes of the striatal 3H-spiperone binding 3-6 weeks after nigrostriatal denervation and after two years.
Guerin B; Silice C; Mouchet P; Feuerstein C; Demenge P
Life Sci; 1985 Sep; 37(10):953-61. PubMed ID: 3162072
[TBL] [Abstract][Full Text] [Related]
2. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
Van der Werf JF; Van het Schip F; Sebens JB; Korf J
Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
[TBL] [Abstract][Full Text] [Related]
3. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
5. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
Creese I; Snyder SH
Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
[TBL] [Abstract][Full Text] [Related]
6. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
7. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
[TBL] [Abstract][Full Text] [Related]
8. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
Kozlowski MR; Neve KA; Grisham JE; Marshall JF
Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
[TBL] [Abstract][Full Text] [Related]
9. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
[No Abstract] [Full Text] [Related]
10. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
11. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
12. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum.
Feuerstein C; Demenge P; Caron P; Barrette G; Guerin B; Mouchet P
Brain Res; 1981 Dec; 226(1-2):221-34. PubMed ID: 7296288
[TBL] [Abstract][Full Text] [Related]
13. [3H]spiperone binding in the nigrostriatal system in human brain.
Ruberg M; Bokobza B; Javoy-Agid F; Montfort JC; Agid Y
Eur J Pharmacol; 1984 Mar; 99(2-3):159-65. PubMed ID: 6203765
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic D-3 binding sites are not presynaptic autoreceptors.
Leff SE; Creese I
Nature; 1983 Dec 8-14; 306(5943):586-9. PubMed ID: 6417548
[TBL] [Abstract][Full Text] [Related]
15. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
[TBL] [Abstract][Full Text] [Related]
16. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.
Neve KA; Marshall JF
Neurosci Lett; 1984 Apr; 46(1):77-83. PubMed ID: 6203067
[TBL] [Abstract][Full Text] [Related]
17. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
18. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
[TBL] [Abstract][Full Text] [Related]
19. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
Nielsen EB; Nielsen M; Braestrup C
Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
